Off-label use of medicines in paediatric inpatients at an Australian teaching hospital

Journal of Paediatrics and Child Health

Volumn 49, Issue 1, 2013, Pages 38-42

  Ballard, Christopher D J ^a   Peterson, Gregory M ^a   Thompson, Angus J ^a   Beggs, Sean A ^a,b  

^a UNIVERSITY OF TASMANIA   (Australia)

^b ROYAL HOBART HOSPITAL   (Australia)

Author keywords

general paediatrics; pharmacology; quality use of medicine

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFALEXIN; CEFAZOLIN; COTRIMOXAZOLE; DEXAMETHASONE; FLUCLOXACILLIN; FLUTICASONE; GENTAMICIN; IBUPROFEN; METRONIDAZOLE; MORPHINE; ONDANSETRON; OXYCODONE; PARACETAMOL; PENICILLIN G; PREDNISOLONE; ROXITHROMYCIN; SALBUTAMOL; TRIMETHOPRIM;

ADVERSE DRUG REACTION; ARTICLE; AUSTRALIA; CHILD; DRUG DOSE; DRUG DOSE REGIMEN; FEMALE; HUMAN; INFANT; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEWBORN; OFF LABEL DRUG USE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SEASONAL VARIATION; TEACHING HOSPITAL;

CHILD; CHILD, PRESCHOOL; FEMALE; HOSPITALS, TEACHING; HUMANS; INFANT; INFANT, NEWBORN; MALE; OFF-LABEL USE; PEDIATRICS; PHYSICIAN'S PRACTICE PATTERNS; RETROSPECTIVE STUDIES; SEASONS; TASMANIA;

EID: 84872502207     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/jpc.12065     Document Type: Article

References (26)

1. Australian Register of Therapeutic Goods. Therapeutic Goods Administration, Department of Health and Ageing, Australian Government. 2010. Available from: http://www.tga.gov.au/industry/%20artg.htm [accessed 6 September 2010].
2. eMIMS. eMIMS Prescribing Information. Sydney: MediMedia Australia Pty Ltd, 2010.
3. Bicknell ME, Weekes LM,. Off-label drug use in an outpatient setting-a pilot study. Aust. J. Hosp. Pharm. 1995; 25: 527-529.
4. Turner S,. Unregistered and off-label drug use in paediatric inpatients. Aust. J. Hosp. Pharm. 1999; 29: 265-268.
5. O'Donnell CP, Stone RJ, Morley CJ,. Unlicensed and off-label drug use in an Australian neonatal intensive care unit. Pediatrics 2002; 110: e52.
6. Tan E, Cranswick NE, Rayner CR, Chapman CB,. Dosing information for paediatric patients: are they really 'therapeutic orphans'? Med. J. Aust. 2003; 179: 195-198.
7. Shirkey H,. Therapeutic orphans. J. Pediatr. 1968; 72: 119-120.
8. Conroy S, Choonara I, Impicciatore P, et al. Survey of unlicensed and off label drug use in paediatric wards in European countries. European Network for Drug Investigation in Children. Br. Med. J. 2000; 320: 79-82.
9. Di Paolo ER, Stoetter H, Cotting J, et al. Unlicensed and off-label drug use in a Swiss paediatric university hospital. Swiss Med. Wkly 2006; 136: 218-222.
10. Hsien L, Breddemann A, Frobel AK, Heusch A, Schmidt KG, Laer S,. Off-label drug use among hospitalised children: identifying areas with the highest need for research. Pharm. World Sci. 2008; 30: 497-502.
11. Santos DB, Clavenna A, Bonati M, Coelho HLL,. Off-label and unlicensed drug utilization in hospitalized children in Fortaleza, Brazil. Eur. J. Clin. Pharmacol. 2008; 64: 1111-1118.
12. t'Jong GW, van der Linden PD, Bakker EM, et al. Unlicensed and off-label drug use in a paediatric ward of a general hospital in the Netherlands. Eur. J. Clin. Pharmacol. 2002; 58: 293-297.
13. Charney RL, Yan Y, Schootman M, Kennedy RM, Luhmann JD,. Oxycodone versus codeine for triage pain in children with suspected forearm fracture: a randomized controlled trial. Pediatr. Emerg. Care 2008; 24: 595-600.
14. Kokki H, Lintula H, Vanamo K, Heiskanen M, Eskelinen M,. Oxycodone versus placebo in children with undifferentiated abdominal pain: a randomized, double-blind clinical trial of the effect of analgesia on diagnostic accuracy. Arch. Pediatr. Adolesc. Med. 2005; 159: 320-325.
15. Kemp C, McDowell J,. Paediatric Pharmacopoeia 13th Ed.: Pharmacy Department, Royal Children's Hospital Melbourne; 2005.
16. Rossi S, ed. Australian Medicines Handbook 2011. Adelaide: Australian Medicines Handbook Pty Ltd, 2011.
17. Pokela ML, Anttila E, Seppala T, Olkkola KT,. Marked variation in oxycodone pharmacokinetics in infants. Paediatr. Anaesth. 2005; 15: 560-565.
18. Barclay ML, Begg EJ, Hickling KG,. What is the evidence for once-daily aminoglycoside therapy? Clin. Pharmacokinet. 1994; 27: 32-48.
19. National Asthma Council Australia. Asthma Management Handbook 2006. Melbourne: National Asthma Council Australia Ltd, 2006.
20. Alhashimi D, Al-Hashimi H, Fedorowicz Z,. Antiemetics for reducing vomiting related to acute gastroenteritis in children and adolescents. Cochrane Database Syst. Rev. 2009; (2): CD005506.
21. Kozer E, Greenberg R, Zimmerman DR, Berkovitch M,. Repeated supratherapeutic doses of paracetamol in children-a literature review and suggested clinical approach. Acta Paediatr. 2006; 95: 1165-1171.
22. Antibiotic Expert Group. Therapeutic Guidelines: Antibiotic, Version 14. Melbourne: Therapeutic Guidelines Limited, 2010.
23. Guerra MM, Garcia E, Pilan RR, Rapoport PB, Campanholo CB, Martinelli EO,. Antibiotic use in post-adenotonsillectomy morbidity: a randomized prospective study. Braz. J. Otorhinolaryngol. 2008; 74: 337-341.
24. Aagaard L, Hansen EH,. Prescribing of medicines in the Danish paediatric population outwith the licensed age group: characteristics of adverse drug reactions. Br. J. Clin. Pharmacol. 2011; 71: 751-757.
25. Neubert A, Dormann H, Weiss J, et al. The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients. Drug Saf. 2004; 27: 1059-1067.
26. Beggs S,. Australian report on pediatric medication issues: is any magic happening in the 'land of Oz' to save the therapeutic orphan? Paediatr. Drugs 2009; 11: 38-40.